Publications

Biopharmaceutical Manufacturing Growth - Pharmaceutical Technology, Shriya Bhatkhande, February 2023.

Single-Use Bioprocessing Technologies Enabling More Rapid Vaccines Production - American Pharmaceutical Review, Shriya Bhatkhande, April 2023.

Demand Surges for Cell and Gene Therapy Contract Manufacturing - Contract Pharma, Arvind S. Deol and Eric S. Langer, May 2023.

Post-COVID Supply-Chain Challenges Are Easing, Part 1: New Competition Is Changing Industry’s Buying Behavior - BioProcess International, Eric Langer and Bob Brooks, BioPhorum, June 2023.

Post-COVID Supply-Chain Challenges Are Easing, Part 2: Impact of Increased Vendor Competition on Pricing - BioProcess International, Eric Langer and Bob Brooks, BioPhorum, August 2023.

Staffing Shortages: Major Hurdle for Bioprocess Contract Manufacturing Services in 2023 - BioPharm International, Shriya Bhatkhande, August 2023.

Survey Results Show What Could Finally Make Sustainability Stick - BioProcess Online, Doug Nissinoff, September 2023.

CPHI report: China develops own biologics niche; no longer low-cost manufacturer - Bioprocess International, Vicky Xia, September 2023.

Symbiotic Success: How CDMOs Shaped a Decade of Biomanufacturing - Contract Pharma, Doug Nissinoff, October 2023.

Growing Opportunities in Outsourced Biopharma APIs - PharmTech, Doug Nissinoff, October 2023.

Here's Why Outsourcing To CDMOs Doubled In 13 Years - BioProcess Online, Erica Friedman, October 2023.

Modular And Single-use Tech Driving The Future Of Biomanufacturing - BioProcess Online, Erica Friedman, November 2023.

Top 50 Biopharma Products Drive Growth in Contract Manufacturing - Contract Pharma, Arvind S. Deol and Dr. Smita Khanna, November 2023.

Top Biomanufacturing Trends for 2022 - DCAT, Joel Ranck, January 2022

2021's Bioprocessing Year In Review & 7 Key Takeaways - DCAT, Dr. Smita Khanna, January 2022

Bioprocessing Facilities in Asia Consider Domestic Alternatives to Western Suppliers - BioProcessing International, Dr. Smita Khanna, February 2022

The Single-use Bioprocessing Bottleneck & Looking Ahead - BioProcess Online, Dr. Paul Spencer, April 2022

Biopharma In China: The Emerging Global Force Of Domestic Suppliers - BioProcess Online, Vicky Xia and Leo Yang, May 2022

Contract Manufacturing During COVID: Biologics revenue increases 29%, but will this growth be sustainable? - Contract Pharma, Eric Langer, May 2022

2022 Outsourcing Trends In Biopharmaceutical Manufacturing - BioProcess Online, Dr. Smita Khanna, June 2022

Bioprocessing Sees Continued Improvements In Batch Failure Reductions In 2022 - BioProcess Online, Joel Ranck, July 2022

BioPlan report: Buoyant bioprocess space will continue to shine post-COVID - BioProcess International, Dan Stanton, October 2022

Cell and Gene Therapy Contract Manufacturers Are Critical to Industry Success - Contract Pharma, Joel Ranck, September 2022

Will China become an innovation hub? CPHI Annual Report 2022 highlights four key trends in China’s emerging innovative biopharma industry - Pharmaceutical Manufacturing, Vicky Xia, October 2022

The Biopharmaceutical Industry and Bioprocessing: What to Expect in 2021 - DCAT, Ronald A. Rader and Eric S. Langer, January 2021

Top Trends in Biomanufacturing 2020 - BioProcess International, Ronald Rader, February 2021

Economics of Perfusion Culture Media and Upstream Processing - American Pharmaceutical Review, Ronald Rader, Eric Langer, February, 2021

Worldwide Biopharmaceutical CMO Capacity Analysis - BioProcess International, Ronald Rader and Eric Langer, February 2021

The "New Normal": Changing Perceptions on Bioprocess Intensification and Continuous Bioprocessing - BioProcess Online, Ronald A. Rader, March 2021.

Supply Chain Challenges Creating Hurdles to COVID-19 Vaccine Production [PDF] - BioPharm International, Jonathan S. Dakin, April 2021

Cell & Gene Therapy Bioprocessing: Demand For Better Process Control, Expertise & CMOs - BioProcess Online, Ronald Rader and Eric Langer, May 2021

Trends Affecting Biopharmaceutical Manufacturing - BioPharm International, David Lin, September 2021

Biopharma outsourcing goes international - Pharma Manufacturing, David Lin, October 2021

COVID-19 Spurs Growth Of China's Domestic Bioprocessing Suppliers - BioProcess Online, Vicky Xia and Leo Yang, October 2021

2019 FDA Biopharmaceutical Approvals WP (published Jan 2020), Ronald Rader

Biosimilar Pipeline Experiencing 12% Annual Growth: A Progress Update - BioProcess Online, Ronald Rader, March 2020

Covid 19: Impact on Bioprocessing and Outsourcing - Contract Pharma, Ronald Rader and Eric Langer, May 2020

Biomanufacturing: Demand for Continuous Bioprocessing Increasing - Pharmaceutical Technology/BioPharm International, Eric Langer, June 2020

Cell And Gene Therapy Bioprocessing: Hiring And Capacity Crunch On The Horizon - BioProcess Online, Eric Langer June 2020

Culture Media Market Growth Drives Demand For New & Better Technologies - BioProcess Online, Kamna Jhamb, Ph.D., July 2020

COVID-19's Impact On Bioprocessing: Insights From Industry Leaders - BioProcess Online, Ronald A. Rader, Eric S. Langer, and Kamna Jhamb, Ph.D, August 2020

Finding a Committed Bioprocess Supply Distributor in China: Managing Distributors in a Rapidly Growing Market - Genetic Engineering News, Vicky Xia and Leo Yang, September 2020

Samsung’s Drugmaking Future Includes a $2 Billion ‘Super Plant’ Bigger Than the Louvre - Wall Street Journal, Featuring quote from Eric S. Langer, Sept 2020

Cellular and Gene Therapies Face a Manufacturing Capacity Crunch - Pharmaceutical Technology/BioPharm International, Ronald Rader, September 2020

CONTINUOUS BIOPROCESSING: WHEN WILL WE SEE COMMERCIAL SCALE OPERATIONS? - Teknoscienze and ChemOutsourcing, Ronald Rader, October 2020

Biopharma trends accelerate: The pandemic has amplified the industry’s hiring problems and growth - Pharmaceutical Manfacturing, Ronald Rader, October 2020

Accelerating Trends in Bioprocessing COVID-19 Crisis Intensifies Need for Collaborative Solutions - American Pharmaceutical Review, Ronald A. Rader, Eric S. Langer, and Kamna Jhamb, Ph.D, October 2020

Biologics Manufacturing In China: Competition Heats Up Among CMOs & Their Clients - BioProcess Online, Vicky Xia and Leo Yang, October 2020

Global trends and growth opportunities in the biopharmaceutical product development and manufacturing - CPhI, Eric Langer, October 2020

Growth of Domestic Mab Pipeline, Regulatory Reform and New Investment is changing the landscape of Biologics CDMOs in China - CPhI, Vicky Xia and Leo Yang, October 2020

Cell and Gene Therapies: Challenges in Scale-up to Commercial Manufacturing - Results Healthcare, Ronald Rader, December 2020

Bioprocessing Year In Review: 11 Key Trends Accelerated By COVID-19 -  BioProcess Online, Ronald Rader and Eric Langer, December 2020

Biomanufacturing Capacity and Supplies: COVID’s Impact - DCAT, Ronald Rader and Eric Langer, December 2020

The Outlook for CMO Outsourcing in 2019 - BioPharm International, Jan 2019, Ronald Rader and E. Langer

Worldwide Biopharmaceutical CMO Capacity Analysis - Feb 2019, BioProcess International, Ronald Rader and and E. Langer

Part 2 - Can China Become a Top Destination for Biologics Manufacturing? - Market Research Blog, Feb 18, 2019, Eric Langer

China Can Be Ignored No Longer: Long-Term Biopharmaceutical Opportunities Based on Near-Term Demonstrated Growth - BioProcess International, March 2019, Vicky (Qing) Xia and E. Langer

Biosimilars Set to Further Expand the Biopharmaceutical Market - American Pharmaceutical Review, March 2019, Ronald Rader and E. Langer

CMOs Leading the Way on Single-Use Systems Adoption - Pharmaceutical Technology, March 2019, Ilene Roizman and E. Langer

Biosimilars Pipeline Shows Remarkable, Sustained Growth - BioProcess Online, March 2019, Ronald Rader

Disposables/Single-Use Roundtable - American Pharmaceutical Review, March 2019, Eric Langer

Bioprocessing Facilities and FDA Inspection Problems, BioPharm International/Pharmaceutical Technology, May 2019, Ronald A. Rader

China Looks Inward and Outward: Investments in US and EU Biopharmaceutical Companies Are on the Rise, BioProcess International, May 2019, Vicky Xia and Eric S. Langer

Trends In Single-Use System Adoption In The Biopharma Industry, BioProcess Online, June 2019, Ilene Roizman

Good Manufacturing Practice in China: Equipment Strategy and Quality Management to Compete with the West, BioProcess International, June 2019, Vicky Xia

Outsourcing in China: How far can it go?, Contract Pharma, July 2019, Vicky Xia

Asia Bioprocessing Capacity Trends: Overall Growth, But Cell Therapy Shortages Loom, BioProcess Online, August 2019, Vicky Xia,

Biopharmaceutical Growth in China: Bioprocessing Challenges Are Creating CMO Opportunities, BioProcess International, September 2019, Vicky Xia, Leo Yang and Eric S. Langer

Trends To Watch In China's Biopharma Industry, BioProcess Online, October 2019, Vicky Xia

China’s single-use craze, Pharma Manufacturing, October 2019, Vicky Xia

Trends in Biopharma Contract Manufacturing in China and India, CPhI, November 2019, Vicky Qing Xia & Ronald A. Rader

Biopharma Over 20 Years, Contract Pharma, K. John Morrow, Jr. and E. Langer, November 2019

The next decade of cleanrooms, Pharmaceutical Manufacturing, Ronald A. Rader, December 2019

Biopharma Year in Review - Looking Ahead to 2020, Pharmaceutical Online/BioProcess Online, December 2019, K. John Morrow Jr. and E. Langer

Biosimilars on Cusp of Far-Reaching Impact; BioCompare; January 2018, Ronald A. Rader

Current Challenges in Bioprocesses Development; Pharmaceutical Technology; March 2018, Ronald A. Rader

CMOs & Biosimilars Mfg. in the U.S.; Contract Pharma; April 2018, Eric S. Langer and Ronald A. Rader

Contract Biomanufacturing in China: Creating a New Segment; Contract Pharma; April 2018, Vicky Xia and Leo Yang.

eBook: The Commercial Expression Systems Market — What Has Changed in the Past Decade; BioProcess International; May 2018, R. Rader

Demand for Capacity Drives China's Biomanufacturing Expansion; BioProcess International; June 2018, Vicky Qing Xia and Leo Cai Yang

Fifteen Years of Progress: Biopharmaceutical Industry Survey Results; BioPharm International; July 2018, R. Rader

Biopharmaceutical Manufacturing is Shifting to Single-Use Systems. Are the Dinosaurs, the Large Stainless Steel Facilities, Becoming Extinct?;American Pharmaceutical Review; October 2018, E. Langer.

Top 12 Biopharma Manufacturing Trends; Genetic Engineering News; October 2018, E. Langer.

Improving Training in Biopharmaceutical Manufacturing; BioProcess Online; October 2018, I. Roizman and E. Langer.

7 Reasons There Was Never Going To Be A Bioprocessing Capacity Crunch; Outsourced Pharma; October 2018, Louis Garguilo (interview with R. Rader and E. Langer).

eBook: Biopharma Manufacturing Markets: Biomanufacturing contract services and supplies markets continues to expand; Contract Pharma; November 2018, R. Rader and E. Langer.

Staffing shortage leaving blockbuster biologics undeveloped, says expert; BioProcess International; November 2018, Dan Stanton (interview with E. Langer).

eBook: Single-Use Bioprocessing Equipment Trends and Adoption by CMOs; Pharmaceutical Technology; November 2018, R. Rader and E. Langer.

Biopharma Market: An Inside Look; Pharmaceutical Manufacturing; November 2018, R. Rader and E. Langer.

Part 1 - China Biopharmaceutical Growth Exceeding Western Projections - Market Research Blog, Nov 28, 2018, Eric Langer

Top Trends In The Biopharmaceutical Industry And Bioprocessing For 2019; BioProcess Online; December 2018, R. Rader and E. Langer.

Overcoming The Manufacturing Hurdles Of Cell & Gene Therapy;
BioProcess Online; February 2017, R. Rader

Modular Bioprocess Facilities Expanding Capacity in China;
Genetic Engineering News; March 2017, V. Xia

CMOs Hiring Constraints: Cell Therapy Manufacturing Expecting Future Challenges;
Contract Pharma; March 2017, E. Langer

Biosimilar Markets and Regulation: Which Countries Are Going All In?
BioProcess International; April 2017; R Rader

Staffing for China's Rapidly Growing Biomanufacturing Industry;
Pharmaceutical Technology; April 2017, V. Xia

CMOs & Biosimilars Mfg. in the U.S.;
Contract Pharma; April 2017, E. Langer and R. Rader

Trends in Bioprocess Automation: Quality Control and Process Analytical Technology in High Demand;
BioProcessing Journal; Spring 2017, K. Estes and E. Langer

Driving Bioprocessing Efficiency;
Pharmaceutical Manufacturing; May 2017, K. Estes and E. Langer

China Biopharma: Is a Wave of GMP Exports in Our Future?;
PharmaFocus Asia; May 2017, V. Xia, L. Yang, E. Langer

Update on Continuous Bioprocessing: From the Industry’s Perception to Reality;
Pharmaceutical Technology; June 2017, K. Estes and E. Langer

Chinese And Indian GMP Biologics Exports: Surveying The Current Landscape;
BioProcess Online; June 2017, V. Xia, L. Yang, E. Langer

Trends in New Technologies & Budgets;
Contract Pharma; June 2017, E. Langer

Trends in Biopharma Contract Manufacturing in China and India;
Pharmaceutical Outsourcing; June 2017, V. Xia and R. Rader

2 part series - Chinese & Indian Expectations For GMP Biologics Exports — A Comparative Assessment;
BioProcess Online; July 2017, V. Xia, L. Yang, E. Langer

Current Trends in Analytical Testing;
Contract Pharma; May 2017, E. Langer

Biosimilars Paving The Way For Cost-Effective Bioprocessing;
BioProcess Online; August 2017, R. Rader and E. Langer

Outsourcing Trends in Biopharmaceutical Manufacturing;
Pharmaceutical Outsourcing; September 2017, E. Langer

Trends and Growth in Single-Use System (SUS) Adoption;
American Pharmaceutical Review; October 2017, E. Langer

Downstream Gears Up;
Pharmaceutical Manufacturing; November 2017, E. Langer

Cell and Gene Therapies: Industry Faces Potential Capacity Shortages;
Genetic Engineering News; November 2017, Ronald Rader

Bioprocessing Trends To Watch In 2018;
BioProcess Online; December 2017, E. Langer

Hiring and Staffing in Biopharmaceutical Manufacturing: Five-Year Trends Indicate Difficulty in Filling Positions
Bioprocess International; January 2016; E. Langer

Alternatives to Protein A: Who's Investigating?;
Genetic Engineering News; February 2016, E. Langer

New Technologies for Fill-Finish; CMOs Are Well Positioned as Early Adopters;
Genetic Engineering News; February 2016, E. Langer

Taking Stock of Biopharma's Outsourcing Markets;
Contract Pharma; February 2016, E. Langer

CMOs Step Up in Areas Where BioPharma is Short-Staffed;
Pharmaceutical Outsourcing; March 2016, E. Langer

What's Holding Back Single-Use Adoption?;
Pharmaceutical Processing; March 2016, E. Langer

Innovation Continues in Single-Use;
Genetic Engineering News; March 2016, E. Langer

4 Key Trends In Biopharmaceutical Manufacturing In 2016;
BioProcess Online; April 2016, E. Langer

Biosimilars Outsourcing and Capacity: CMOs to play important but uncertain role in biosimilars manufacturing;
Contract Pharma; May 2016, R. Rader and E. Langer

CMOs Demanding Easier-to-Integrate Single-use Devices Disposables' implementation and integration critical; suppliers being put on notice;
Contract Pharma; May 2016, J.C. Lupis and E. Langer

Future Manufacturing Strategies for Biosimilars;
BioProcess International; May 2016, R. Rader and E. Langer

Outsourcing of Biomanufacturing in 2016;
Pharmaceutical Technology; May 2016, E. Langer

Biosimilars Segment—A Fast-Moving Blur;
Genetic Engineering News; June 2016, E. Langer

Biomanufacturing Outsourcing Budgets Grow, Slowly;
Pharmaceutical Technology; June 2016, E. Langer

Microbial Platforms Set for Rapid Growth;
Genetic Engineering News; July 2016, E. Langer

Contract Manufacturing Budget Trends: Study shows where the money is, and isn't, flowing;
Contract Pharma; July 2016, E. Langer

Biosimilars Pipeline Analysis: Many Products, More Competition Coming;
BioProcess Online; July 2016, R. Rader

CMOs and Innovation;
Pharmaceutical Outsourcing; August 2016, E. Langer

Hiring Difficulties Compound Downstream Processing Woes;
Genetic Engineering News; September 2016, E. Langer

Economics of In-House Buffer Preparation: Evaluating the cost effectiveness of keeping basic ops in-house;
Contract Pharma; September 2016, E. Langer

Biopharmaceutical Manufacturing Globalization Continues;
Pharmaceutical Outsourcing; September 2016, E. Langer

Average Batch Failure Rate Worsens;
Genetic Engineering News; October 2016, E. Langer

Outsourcing of Buffer Preparation Activity Is Increasing;
Genetic Engineering News; October 2016, E. Langer

Fill/Finish Outsourcing: This key bioprocessing segment is expecting continued growth,
Pharmaceutical Technology; October 2016, E. Langer

Continuous Bioprocessing Overtakes Single-Use On List Of Top Technology Trends;
BioProcess Online; October 2016, E. Langer

Outsourcing of Buffer Preparation Activity Is Increasing;
BioProcess International; November 2016, E. Langer

Year-End Trends in Biopharma Contract Manufacturing;
Contract Pharma; November 2016, E. Langer

Manufacturing Costs Will Be Critical to Biosimilars' Success;
Pharmaceutical Manufacturing; November 2016, R. Rader

Biopharmaceutical Manufacturing Growing Rapidly in China: More and More Firms Are Setting Their Sights on Genuine, Major Market Acceptable Biosimilars;
Genetic Engineering News; December 2016, E. Langer

India's Next Steps: Quality Improvements Target International Markets;
BioProcess International; December 2016, E. Langer

Biopharmaceutical Manufacturing Growing Rapidly in China;
Genetic Engineering News; December 2016, E. Langer

Biosimilars Supporting Contract Manufacturers' Growth: Biosimilars may be the key to CMO growth.;
Pharmaceutical Technology; December 2016, E. Langer

2017 Biopharmaceutical Trends — Opportunities For The New Year;
BioProcess Online; December 2016, E. Langer

Fill/Finish Capacity Use for Biologics
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; January 2015, E. Langer

Biosimilars Impacting CMO Capacity
Pharmaceutical Outsourcing; February 2015; E. Langer

7 Top Trends in Biomanufacturing Outsourcing
Contract Pharma January 2015; E. Langer and J.C. Lupis

CMO's Plan for Capacity Expansions
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; March 2015, E. Langer

30 Years of Upstream Productivity Improvements
BioProcess International; February 2015; R. Rader and E. Langer

A Fully Disposable Bioprocessing Facility: Is it on the horizon?
Pharma IQ; February 2015; E. Langer

Outsourcing Budgets Continue to Shine: Preliminary study data indicates continued spending on outsourcing
Contract Pharma; April 2015, E. Langer

CMOs Plan for Capacity Expansions
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe ; March 2015; E. Langer

Biomanufacturing Outsourcing Globalization Continues
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; May 2015; E. Langer

Leachables And Extractables In Single-Use: Trends and Expectations Over Plastics Innovation
BioProcess Online, LSL ; March 2015; E. Langer

Biosimilars Improving Efficiency, Cost for All Biologics
Contract Pharma; April 2015, E. Langer

BioPharma Industry Seeks Downstream Processing Advances
Pharmaceutical Processing; June 2015; E. Langer

Creating Effective Leachables and Extractables Testing: Whose Responsibility Is It?
Pharma IQ; April 2015; E. Langer

Another In-House Operation Gets Outsourced
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; June 2015; E. Langer

Key Trends Shaping Fill/Finish Operations From Single-Use Adoption to CMO Acquisitions— Trends to Watch for This Year
American Pharmaceutical Review/Pharmaceutical Outsourcing; May 2015; E. Langer

Critical Trends Driving BioManufacturing Production Strategies
Pharmaceutical Manufacturing; June 2015; E. Langer

CMOs Demanding Easier-to-Integrate Single-use Devices
Contract Pharma; May 2015; E. Langer and J.C. Lupis

Single-Use Standardization: Is It Holding Back The Biopharma Industry?
BioProcess Online, LSL; June 2015; E. Langer

Hiring in Biopharma: Rapid Industry Growth is Creating Bottlenecks
Pharmaceutical Processing; July 2015; E. Langer

Getting to Yes
Contract Pharma; July 2015; E. Langer

New Technologies for Downstream Efficiencies
Pharmaceutical Manufacturing; June 2015; E. Langer

Outsourcing Becoming More Cost Competitive
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; August 2015; E. Langer

Single-Use Systems Not Helping Downstream Bioprocessing, Yet… Alternatives to Chromatography Still Slow in Adoption
American Pharmaceutical Review; July 2015; E. Langer

Is Biopharma Ready to Say Goodbye to Batches?
Medicine Maker; August 2015; E. Langer

CMOs Concerned With Cost of Single-Use Equipment
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe; September 2015; E. Langer

Single-Use Systems Not Helping Downstream Bioprocessing, Yet… Alternatives to Chromatography Still Slow in Adoption
American Pharmaceutical Review; July 2015; E. Langer

CMOs Are Willing to Pay for More Innovation
Contract Pharma; September 2015; E. Langer

Bio Pharma Manufacturing's Top 15 Trends for 2015
Pharmaceutical Manufacturing; August 2015; E. Langer and J.C. Lupis

Efficiency Leads to Optimization
Pharmaceutical Processing; October 2015; E. Langer

Globalization Hits Biopharma Contract Manufacturing
Contract Pharma; October 2015; E. Langer

Advances in Bioprocessing: Single-Use and Stainless Steel Technologies
BioProcessing International ; December 2015; E. Langer

Biopharmaceutical Manufacturing: Historical and Future Trends in Titers, Yields, and Efficiency in Commercial-Scale Bioprocessing
BioProcessing Journal ; Winter 2015; R. Rader and E. Langer

BRIEF: Critical Trends Driving BioManufacturing Production Strategies
Pharmaceutical Manufacturing; August 2015; J.C. Lupis and E. Langer

Are CMOs Really Going to See a Capacity Pinch?
Genetic Engineering News; November 2015; E. Langer

5 Growing Benefits to Successful Single-Use Implementation
Pharma IQ; October 2015; E. Langer

2015 in Review: 6 Key Trends Affecting CMOs
Contract Pharma ; November 2015; E. Langer

Continuous Bioprocessing in Operation
Genetic Engineering News; December 2015; E. Langer

Cell Culture Media Process Optimization
Genetic Engineering News; December 2015, E. Langer

Regulatory Concerns For Facilities Of The Future: Does Flexibility Come With A Cost?
BioProcess Online, LSL; December 2015; E. Langer

Year in Review: Key Outsourcing Trends to Watch This Year
Pharmaceutical Outsourcing, January 2014; E. Langer

Novel Expression Systems Opening CMO Opportunities
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, January 2014; E. Langer

Who's Improving Bioprocessing In 2014
Life Science Leader, January 2014; E. Langer

Continuous Bioprocessing and Perfusion: Wider Adoption Coming as Bioprocessing Matures
BioProcessing Journal, Spring 2014; E. Langer

Outsourcing trends in Biopharmaceutical Manufacturing
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, February 2014; E. Langer

Single Use Technologies in Biopharmaceutical Manufacturing: A 10-year Review of Trends and the Future
Engineering in Life Sciences, May 2014; E. Langer

Too Much CMO Capacity? Biomanufacturers plan their 2018 capacity expansions
Contract Pharma, March 2014; E. Langer

Novel Expression Systems Opening CMO Opportunities
Pharmaceutical Technology, February 2014; E. Langer

Best Practices in Biomanufacturing Supplier Relations: Reducing Raw Materials Risks
Life Science Leader; February 2014; E. Langer

Bioprocess Advances Drive Vaccine Manufacturing in Developing Countries
BioProcess International, February 2014; E. Langer and R. Rader

Innovation Is This Year's Magic Wand
Genetic Engineering News, March 2014; E. Langer

Powders and Bulk Liquids
Bioprocess International, March 2014; E. Langer and R. Rader

Innovation in Pre-packed Disposable Chromatography Columns
BioPharm International Supplement, March 2014; E. Langer

Manufacturers Open Their Wallets for Outsourcing: Accessing Technical Expertise and Cutting Costs
BioProcess International, April 2014; E. Langer

Biopharma Quality Management Best Practices: An Approach to Quality Initiatives
Life Science Leader, April 2014; E. Langer

Outsourcing No Longer Just for Cost-Cutting
Pharmaceutical Technology, May 2014; E. Langer

CMOs Most Critical to Success Factors
Pharmaceutical Processing, April 2014; E. Langer

Bioprocessors Demanding Single-Use Sensors Best Practices
Life Science Leader, May 2014; E. Langer

Bioprocessing Trends to Expect in 2014
Genetic Engineering News, June 2014; E. Langer

Bio/Pharma Industry Improves Downstream Operations Best Practices: Membrane Technology Options
Life Science Leader, July 2014; E. Langer

BioPharma Unhappy With Suppliers’ Progress on Single-Use Hookups
BioProcess International, September 2014; E. Langer

Outsourcing Trends in Biopharmaceutical Manufacturing
BioPharm International Supplement, August 2014

Biopharm Executives Point to Better CMO Performance
Contract Pharma, October 2014; E. Langer

Outsourcing Grows in Europe
Pharmaceutical Technology Europe, August 2014; E. Langer

Outsourcing Media and Buffer Prep
Contract Pharma, September 2014; E. Langer

Targeting Different Offshore Destinations
Pharmaceutical Technology, September 2014; E. Langer

Outsourcing Economic Models Are Changing
Life Science Leader, September 2014; E. Langer

Moving Beyond the Batch: Best Practices, Opportunities and Challenges in Continuous Bioprocessing
Life Science Leader, October 2014; E. Langer

Bioprocessing Challenges of Antibody-Drug Conjugates
BioProcess International, October 2014; R. Rader

Budgets Increase to Support Single-Use Bioprocessing
BioPharm International, November 2014; E. Langer

Single-use Disposables are Future Proofing Biopharmaceutical Manufacturing
PharmaIQ, October 2014; E. Langer

The Biosimilars Opportunity: 4-years of Waiting
Life Science Leader, October 2014; E. Langer

Biopharm Executives Point to Better CMO Performance
Contract Pharma, October 2014; E. Langer

Risks and Rewards in the U.S. BioSimilars Pipeline
Pharmaceutical Manufacturing, October 2014; E. Langer

The US Biosimilars Future Is Hard to Predict: Global Health Policy, Innovation, Prices, and Profits Are All at Stake
BioProcess International, December 2014

Biomanufacturing Industry Not Providing Employees the Tools to Succeed
Life Science Leader, November 2014; E. Langer

Year in Review: Trends in Biopharma Manufacturing Outsourcing
Pharmaceutical Technology, December 2014; E. Langer

Critical Innovation BioProcessing Trends For 2014
Life Science Leader, December 2013; E. Langer

Disposable Chromatography: Options Are Increasing Requirements for greater productivity and efficiency are moving interest toward disposable options
Genetic Engineering News, December 2013; E. Langer

Biopharmas Increasingly Satisfied With Vendors Of Single-Use Products
Life Science Leader, December 2013; E. Langer

Future proofing biopharmaceutical manufacturing: the industry seeks a leaner version of itself
Future Science, December 2013; E. Langer and R. Rader

CMOs Demanding More Innovations
Contract Pharma, November 2013

Innovation In Stainless-Steel Bioprocessing
Life Science Leader, October 2013; E. Langer and R. Rader

Seeking Innovation to Solve Persistent Problems
Pharmaceutical Manufacturing, November 2013; E. Langer

Bio-CMO Capacity Constraints
Contract Pharma, September 2013; E. Langer

Industry Adoption of Membrane Adsorbers
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, October 2013; E. Langer

Client Relationships: How CMOs Can Avoid The Pitfalls
Life Science Leader, October 2013; E. Langer

Innovation In Alternative Chromatography
Life Science Leader, October 2013; E. Langer

PAT Adoption Hurdles Remain
Pharmaceutical Manufacturing, October 2013; E. Langer

Making the Best of a Bad CMO-Client Relationship
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, September 2013; E. Langer

Innovation In Expression Systems Yields Increase Productivity
BioProcess Online, August 2013; E. Langer

Bioprocessing Advances in Vaccine Manufacture
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, September 2013; E. Langer and R. Rader

What Happened to Outsourcing in Asia?
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, August 2013; E. Langer

Innovation In Disposable Connectors
Life Science Leader, July 2013; E. Langer

Demand For Innovation In High-Value Bioprocessing
Life Science Leader, June 2013; E. Langer

Disposable Applications Penetrate Biomanufacturing Market
Pharmaceutical Manufacturing, June 2013; E. Langer

Keeping New Technologies Coming
BioProcess International, June 2013; E. Langer

Outsourcing's Modest Role as a Cost-Containment Strategy
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, May 2013; E. Langer

CMOs Leading The Way In Biopharma Innovation – No Herd Mentality
Life Science Leader, May 2013; E. Langer

Outsourcing of Fill-Finish Operations Continues
Pharmaceutical Processing, April 2013; E. Langer

Global Changes in Biomanufacturing; A retrospective analysis of CMO Trends
Contract Pharma, April 2013, E. Langer

Single-use Bioprocessing Sensor Innovation Is In Need
Life Science Leader, April 2013; E. Langer

Vendors Ignore Calls For Innovation In Assays
Life Science Leader, April 2013; E. Langer

Biopharma Continues Globalization Efforts
Global Corporate Xpansion, April 2013; E. Langer

Focus on Efficiency: Single-use, analytical methods and downstream processing at the forefront.
Pharmaceutical Manufacturing, March 2013; E. Langer

Outsourcing of Non-traditional Protein Expression Systems Increases
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, April 2013; E. Langer

The Big Squeeze
European Biopharmaceutical Review, Spring 2013; E. Langer

Fill-Finish Innovation: Showing Sparks of Life
Contract Pharma, March 2013; E. Langer and R. Rader

Innovation In Assays And Analytical Methods Urgently Needed
Life Science Leader, February 2013; E. Langer

Biopharmas Increasingly Satisfied With Vendors Of Single-Use Products
Pharmaceutical Online, February 2013; E. Langer

The Future of BioPharma
BioPharma International/Pharmaceutical Technology and Pharmaceutical Technology Europe, February 2013; E. Langer

Offshoring Biomanufacturing
Pharmaceutical Technology, February 2013; E. Langer

Breaking the Biotech Bottleneck: Downstream capacity still lags behind upstream, but shortages are now “acute” rather than “chronic
Pharmaceutical Manufacturing, January 2013; E. Langer

Sponsors Look to Asia for Potential Contract Partners
BioProcessing International, January 2013; E. Langer

Biopharma Outsourcing Leveling Out
Pharmaceutical Online, August 2012, Eric Langer

Gauging Biopharm Outsourcing
Pharmaceutical Technology August 2012, Eric Langer PDF

CMOs and Biodevelopers Taking Different Approaches to DSP Problems: CMOs Get Serious About New Technologies
E. Langer, Pharmaceutical Outsourcing, July 2012 PDF

Top 50 (or so) Biopharma Products: Ranking the top 57 biopharma products by 2011 revenues - Contract Pharma, Ronald Rader, July 2012

BioPharma Industry Gives the Nod to Single-Use Bioreactors
E. Langer, Genetic Engineering News, July 2012 PDF

Biomanufacturing Innovation
E. Langer, BioPharm International, July 2012 PDF

Biopharmas Increasingly Satisfied with Vendors of Single-Use Products
E. Langer, Life Science Leader, July 2012 PDF

Biomanufacturers Looking for Single-Use Innovations
E. Langer, Pharmaceutical Online, June 2012

Biomanufacturing Shows Signs of Maturity, PAT Adoption
E. Langer, June 2012 PDF

Biomanufacturing Innovation
E. Langer, Pharmaceutical Technology, June 2012 PDF

25 Years of Biopharma Industry Growth
E. Langer, BioPharm International, June 2012 Special Issue PDF

Hiring In Biopharma — Where Are The Jobs Going Next?
E. Langer, Life Science Leader, May 2012 PDF

10 years of biomanufacturing: Industry maturity shown in the shifts toward process improvement
E. Langer, BioProcess International, May 2012 PDF

Single-Use Technologies Used Less for Downstream Purification Issues
E. Langer, Pharmaceutical Online, May 2012 PDF

Bio-Growth Slowing?
E. Langer, Contract Pharma, May 2012 PDF

Productivity Focus: CMOs Look to Get More From Their Employees
E. Langer, Genetic Engineering News, May 2012 PDF

BioManufacturers Increasing Budgets for New Technologies
Eric Langer, BIO, May 3, 2012

CMOs on the Hunt for Disposable Solutions
E. Langer, Pharmaceutical Processing, April 2012 PDF

BioPharma Industry Getting Comfortable with Complex Single Use Devices
E. Langer, Pharmaceutical Online, March 2012 PDF

Biopharma Vendor Satisfaction: Are Suppliers Doing What’s Best For The Industry?
E. Langer, Life Science Leader, March 2012 PDF

Industry Adopting More Complex Devices
E. Langer, Contract Pharma, March 2012 PDF

Pharmaceutical Outsourcing Trends: The Next Decade
E. Langer, BioPharm International, March 2012 Special Issue PDF

Are Downstream Problems Finally Being Resolved?
E. Langer, BioProcess International, March 2012 PDF

Biosimilars and Biobetters
Eric Lanager, Pharmaceutical Processing, Feb 2012

Biomanufacturing Outlook
Eric Langer, Pharmaceutical Technology, Feb 2012 PDF

Biopharma Manufacturers Looking for Product Innovation
E. Langer, Life Science Leader, February 2012 PDF

Single Use Biomanufacturing Devices in High Demand
E. Langer, Pharmaceutical Online, February 2012 PDF

Upstream Single-Use Bioprocessing Systems
Ron Rader and Eric Langer, BioProcess International, February 2012 PDF

Biopharmaceutical Industry in 2012: Optimism on the Rise
E. Langer, Pharmaceutical Technology, February 2012

Biopharma Industry Enthusiastic About 2012
Eric Langer, BIO, January 12, 2012

Limited Analytical Technologies Are Inhibiting Industry Growth
E. Langer, October 2011

Top 1000 Global Biomanufacturing Facilities- Insights from real-time ranking of global biomanufacturing capabilities.
E. Langer, BioPharm International, August 2011

Can Outsourcing GMP Operations to China Really Work?
E. Langer, Life Science Leader, August 2011

Single Use Bioreactors Lead in New Use and Market Penetration
E. Langer, Pharma IQ, August 2011

High Tech Single Use Devices, Bioreactors Lead in Market Penetration
E. Langer, Pharma IQ, August 2011

Single Use Devices-Whats REALLY Holding Up Adoption?
E. Langer, Life Science Leader, July 2011

Positive Trends in Biomanufacturing Budgets: Biopharma and Vendor Budgets Are Up For the First Time in Three Years;
E. Langer, BioProcessing Journal, July 2011

Hiring In Biopharma — Where Are The Jobs Going Next?
E. Langer, Life Science Leader, July 2011

Bio-Outsourcing On the Rise: Fewer companies go 100% in-house
E. Langer, Contract Pharma, June 2011

Will Perfusion Be the Next Revolution in Bioprocessing?
E. Langer, BioProcess International, June 2011

Offshoring Biomanufacturing: China rises to the top as a destination for international sourcing
E. Langer, BioProcess International, June 2011

Biomanufacturing Budget Bump-2011's Spending Upswing
E. Langer, PharmaIQ, June 2011

Top 1000 Biomanufacturing Facilities: Knowing where key biomanufacturing facilities are located around the world is essential for decision-making.
E. Langer, BioPharm International, June 2011

Trends in Biopharmaceutical Industry: Budgets Returning...Investing In Innovation...Productivity & Cost Control
E. Langer, Pharmaceutical Manufacturing, June 2011

China Ranked Top Potential Biopharma Outsourcing Destination,
E. Langer, BioProcess International, June 2011

Biotech Budgets: Whose Departments Are Winning?
E. Langer, Life Science Leader, June 2011

Biopharma Wants Better Upstream Bioprocessing Technologies,
E. Langer, Pharmaceutical Technology, May 2011

Downstream Process Bottlenecks: Industry Demanding Better Technologies,
E. Langer, Genetic Engineering News, May 2011

Hiring Trends in Biopharma,
E. Langer, Ashton Tweed, May 2011

Time to Build 'Relationship' into the Outsourcing Process,
E. Langer (BioData Points), Life Science Leader, May 2011

Single Use Technologies Changing the Biomanufacturing Landscape,
E. Langer, Life Science Leader, May 2011

Single Use Trends Boosting Adoption or Vendor Satisfaction,
E. Langer, Pharmaceutical Manufacturing, May 2011

New Plant Expression Systems Drive Vaccine Innovation and Opportunity,
E. Langer, BioProcess International, April 2011

Productivity Bottlenecks Drive the Demand for Innovation,
E. Langer, BioProcess International, March 2011

Improved Downstream Technologies Are Needed to Boost Single-Use Adoption,
E. Langer, BioProcess International, March 2011

Single-Use Products in BioManufacturing: Innovations Driving the Industry,
E. Langer, BioProcess International, March 2011

Need for Access to Enabling Technologies Drives Growth in the Contract Biomanufacturing Market,
Hosted by Andrea Charles, PharmaIQ, March 21, 2011

Biopharmas Doubling Critical Outsourcing Operations; Genetic Engineering News,E. Langer, Genetic Engineering News, February 2011

Changes Underway for Biopharmaceutical Outsourcing More crucial biomanufacturing operations are expected to be outsourced,

Can Biofuels Recover From the Crunch? [496k]
D. Mousdale, BioFpr Journal/Wylie, January 2011

E Langer Presents 2011 Trends for Life Science Leader Journal [369k]
E. Langer, Life Science Leader Journal, January 2011

European Biomanufacturing Efficiency Outstripping US: Outlook for Capacity Utilisation Through 2015
E. Langer, European Biopharmaceutical Review, January 2011

Biofuels: Road to Recovery [160k]
D. Mousdale, BioFuels International, December 2010

Has Big Oil Finally Embraced Biofuels? [246k]
D. Mousdale, BioFuels International, November 1, 2010

Outsourcing Winners in 2014: Post recession and beyond
E. Langer, Pharmaceutical Technology, Nov 2, 2010, pp. 112, 115

Trends to Watch in the Biopharmaceutical Industry [262k];
E. Langer, Pharmaceutical Executive, Supplement for Nov. 2010

Regulatory Challenges Impede Adoption of new Downstream Technologies;
E. Langer, BioPharm International, October 2010

Plant Expression Systems Growing Rapidly, Vaccines Manufacturers Leading the Way [33k];
E. Langer, Genetic Engineering News, October 15, 2010

Downstream Disposables: The Missing Link in the Disposables Chain: Acceptance in has been slow.;
E. Langer, BioPharm International, August 1, 2010

Project Managers Wanted: Relationship management is a limiting factor to growth in biomanufacturing outsourcing;
E. Langer, Pharmaceutical Technology, Aug 2, 2010, pp. 70, 72

Perfusion Bioreactors Are Making a Comeback, But Industry Misperceptions Persist [5.6mb];
E. Langer, BioProcessing Journal, Summer 2010

Managing the Client-Contractor Relationship Increased bio/pharmaceutical outsourcing demands new management skills [1.6mb];
E. Langer, Chimica Oggi / CHEMISTRY TODAY - vol 28 n 4 - July/August 2010

Bio/pharma outsourcing: Strategic initiative, or just passing off low-end jobs [352k];
E. Langer, Chemical Week; July 2010

Will Protein A Be the Long-Term Solution for Your Purification Needs? Cost-effective purification technologies.;
E. Langer, BioPharm International, June 2010

As Biopharma Matures: Working Harder, Getting Leaner;
E. Langer, Pharmaceutical Manufacturing, April 28, 2010

Biomanufacturers' Anxieties Over New Downstream Technologies;
E. Langer, Biopharm International, April 2010

Podcast: Focus on Pharma Episode 4: Maturing Biopharma: The Need to Do More with Less;
E. Langer, Pharmaceutical Manufacturing, April 28, 2010

Biopharma Outsourcing Trends: Client-contractor relationships grow more complex;
E. Langer, Contract Pharma, April 2010

Waste Not, Want Not: Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization;
E. Langer, Pharmaceutical Technology, April 2, 2010, Vol 34, Issue 4, p. 122-124.

Outsourcing Comes of Age;
E. Langer, European Biotech Review, March 2010

Downstream Processing: Promising Technologies are on the Horizon; Beyond traditional chromatography;
E. Langer, BioPharm International, March 2010

Realistic Expectations Likely to Prevail in 2010: As Economy Recovers, Firms in Sector Remain Cautiously Optimistic about Future Growth;
E. Langer, Genetic Engineering News, March 2010

Contract Manufacturing Bucks Economic Downturn: Practitioners Cite Depth of Experience and Formation of a More Mature and Stable Business Model;
E. Langer, Genetic Engineering News, February 2010

Downstream Factors That Will Continue To Constrain Manufacturing Through 2013;
E. Langer Bioprocessing Journal, Winter 2009

Single-Use Technology in Biopharmaceutical Manufacture, part 1;
Brian Lee, Eric Langer, Ran Zheng, Wylie, Book Chapter, February 2010.

A Bio View of Outsourcing: Strategic not tactical considerations are driving decisions in biopharmaceutical outsourcing;
E. Langer, Pharmaceutical Technology, February 2010

Licensing of Expression Systems ;
E. Langer, Biopharm International (December 2009)

Avoiding the Regulatory Catch 22;
E. Langer, Biopharm International (August 2009)

On the Horizon: New Expression Systems to Become Common Industry Platforms ;
E. Langer, Biopharm International (June 2009)

China Increases Healthcare Investment Gov't Investment Is Opening Up Opportunities for Domestic and Multinational Firms [117K PDF];
Qing Xia and Daming Chen, Genetic Engineering News (June 1, 2009)

Capacity Utilization & Capacity Constraints [275K PDF];
E. Langer, Contract Pharma (May 2009)

Tracking Downstream Purification: Downstream is viewed as a capacity constraint now, and figures to remain that way. [544K PDF];
E. Langer, Pharmaceutical Manufacturing (April 2009)

Trends in Single-use Bioproduction [243K PDF];
E. Langer, BioProcess International (April 2009)

Expression Systems Royalties Battle ;
E. Langer, Biopharm International (April 2009)

Biopharma Faces the Future [544K PDF];
E. Langer, Pharmaceutical Manufacturing (April 2009)

Expanding Expression: Beyond CHO, E coli and Yeast [207K PDF];
E. Langer, EBR-European Biopharmaceutical Review (April 2009)

Budgets Shifting in Biopharma Manufacturing [53K PDF];
E. Langer, Genetic Engineering News (April 15, 2009)

Disposables: A growing throw-away culture[651K PDF];
E. Langer, Manufacturing Chemist (7 April 2009)

Trends in Capacity Utilization for Therapeutic Monoclonal Antibody Production [525K PDF];
E. Langer, MABS Journal (March/April 2009)

New Expression Systems Create Opportunities for Innovators, CMOs, and Product Developers ;
E. Langer, Biopharm International (March 2009)

Crunch Time: Finances, not technologies are shaping the future of biopharma [488K PDF];
E. Langer, World Pharmaceutical Frontiers (March 2009)

Riding the Dragon Biotechnology in China: Analysis of Future Directions and Growth of Biotechnology in China [374K PDF];
Qing Vicky XIA, Asia Biotech Directions (2008-2009)

Capitalizing on Novel Expression Systems: Technologies Make Products More Efficiently [112K PDF];
E. Langer, Genetic Engineering News (January 15, 2009)

Disposables: Current Trends and Analysis [209K Word];
E. Langer, BioProcess International (January 2009)

Biopharmaceuticals in India: 2008 in Review [48K Word Doc];
E. Langer, Biopharm International (December 2008)

Supplying Biopharma amid a Global Downturn: A passage to India [72K Word Doc];
E. Langer, BioWorld Europe, (December 2008)

Bio-Outsourcing Trends: A new study explores capacity and production issues [84K PDF];
E. Langer, Contract Pharma (Nov/Dec 2008)

Contract Manufacturing in India: Is the CMO Model a Viable Business? [220K PDF];
E. Langer, Biopharm International, (November 2008)

Quantifying Trends Toward Alternatives to Protein A: Survey Results [60K PDF];
E. Langer, BioProcess International, Elucidation, (December 2008)

Critical Issues in Outsourcing to a CMO: Indications of a Maturing Industry [300K PDF];
E. Langer, BioProcess International, (November 2008 Supplement)

Explaining Capacity Expansion [990k PDF];
E. Langer, European Biopharmaceutical Review, (November 2008)

Biomanufacturing Capacity Use, Solid Performance in 2007 [100K PDF];
E. Langer, BioProcess Int'l, (October 2008)

FDA Pushes PAT and Companies Shove Back: Even with Perks, PAT Implementation Remains Stalled [28K PDF];
E. Langer, Genetic Engineering News, (Oct 1 2008)

Biotech Facilities Average Batch Failure Every 40.6 Weeks; Capacity Use, Solid Performance in 2007 [208K PDF];
E. Langer, BioProcess International, (September 2008)

Users Sold on Single-use Systems [44K PDF];
E. Langer, Genetic Engineering News, (September 15, 2008)

Biopharmaceutical Outsourcing Opportunities and Challenges [1.3Mb PDF];
E. Langer, BioOutsourcing Asia-CanBiotech, (October 2008)

Pharmaceutical Distribution in India-Drug Manufacturers struggling to improve fragmented network [#K PDF];
A. Kelkar, E. Langer, Biopharm International (October 2008)

Visible Hand: Indian Government Supports in Biopharmaceutical Industry [164K PDF];
E. Langer, Biopharm International (August 2008)

Batch Failure Rates in Biomanufacturing: Good Training and Equipment Among Solutions [28K PDF];
E. Langer, Genetic Engineering News, (August 2008)

India's Bioinformatics Industry: An Engine for Global Growth [#K PDF];
E. Langer, Biopharm International (July 2008)

Quantifying Downstream Capacity Crunch-Column Resins Implicated in Woes [136K PDF];
E. Langer, Genetic Engineering News, (July 2008)

Bio-Capacity in 2012: The outlook is bright for CMOs [116K PDF];
E. Langer, Contract Pharma, (May 2008)

Downstream Production Impacts Overall Capacity [700K PDF];
E. Langer, BioWorld Europe, (March 2008)

India's Clinical Trials Market Accelerates [204K PDF];
F. Kermani, E. Langer, Biopharm International (May 2008)

Understanding India's New Patent Laws,
E. Langer, Biopharm International (April 1, 2008)

Paucity of Biopharma Approvals Raises Alarm,
R. Rader, Genetic Engineering News (March 15, 2008)

Biologics Regulation in India,
E. Langer, Biopharm International (March 1, 2008)

Top 60 Chinese Biofirms Propel Industry Forward,
E. Zhou, Genetic Engineering News (February 15, 2008)

India's Biogenerics Industry,
E. Langer, Biopharm International (February 1, 2008)

Biopharmaceuticals in India: A New Era,
E. Langer, Biopharm International (January 1, 2008)

China as a Biopharmaceutical Powerhouse: Just a matter of time; Despite serious obstacles, development marches ahead,
E. Langer, Biopharm International, (December, 2007)

Life Science and Biotechnology Education in China,
Eric Langer and Eliza Yibing Zhou, BioPharm International, September 2007

BioChina: A Year in Review;
Eric S. Langer, BioPharm International, August 2007

Next Steps toward Globalization: China's Service Sector,
Eric Langer, Eliza Yibing Zhou, BioPharm International, July 2007

Are Biotechnology Meetings and Symposia Dling the Job?
Eric S. Langer, Final Word-BioPharm International, July 2007

Biogenerics in China: An Evolving Industry:
Eric Langer, BioPharm International, June 2007

Intellectual Property Protection in China: Does it Warrant Worry?
Eric Langer, BioPharm International,. May 2007

Clinical Trials in China: Is China Fulfilling its Promise?
Faiz Kermani and Eric Langer, Contract Pharma, May 2007

Vaccine Development in China,
Eliza Yibing Zhou, BioPharm International. April 2007

Global Trials China: Marching into a New Era,
Faiz Kermani, Good Clinical Practice Journal March 2007

Managing Biopharmaceutical Manufacturing Capacity in 2007,
Eric Langer, BioProcess International, March 2007

China Today: Biopharmaceutical Industry Trends in China—A Five-year Prospective, BioPharm International,
Eliza Yibing Zhou, March 2007

China Pharma Basking in its Spotlight,
Eliza Yibing Zhou, BioPlan Associates, Genetic Engineering News, March 1, 2007

Biopharmaceutical Production Outsourcing Matures,
Eric Langer, BioProcess International, February 2007

Evaluating Disposables: Single-Use Technologies in Biomanufacturing,
Webcast, Biopharm Int'l, Feb 15, 2007

Defining the Chinese Biopharmaceutical Market,
Eric Langer and Eliza Yibing Zhou, BioPharm International, January 2007 p 24

Opportunities in Biopharmaceutical Outsourcing to China,
Eliza Yibing Zhou, BioProcess International, January 2007

Biopharmaceutical Outsourcing in China: A Rapidly Changing Business Environment,
E Langer, European Business Review, Winter 2006

Biomanufacturing Capacity Flat in 2006,
Eric Langer, Contract Pharma, November/December 2006

China-Grown Pharma Products,
Eliza Yibing Zhou, Genetic Engineering News, November 15, 2006

Chinese Biogenerics and Protection of IP,
Eliza Yibing Zhou, Genetic Engineering News, September 1, 2006

Advances in Biopharmaceutical Technology in China, BioPlan Associates, Inc,
Eric Langer, Ed. September 2006

4th Annual Biopharmaceutical Manufacturing Capacity Report and Survey,
June-Sept 2006, BioPlan Associates, Inc.

Biopharmaceutical Approvals Review,
Ronald Rader, Genetic Engineering News, August 2006

Contract Research Drives China's Pharma Sector,
Eliza Yibing Zhou, Pharmaceutical Manufacturing, July/Aug 2006

Biopharmaceutical Products in US and European Markets, 5th Edition,
Ron Rader, BioPlan Associates, Inc, July 2006

Capacity Bottleneck Squeezed by Downstream Processes,
E Langer, J Ranck, BioProcess International, March 2006

Purification Woes Upstage Upstream Gains,
Eric Langer (J. Ranck), Genetic Engineering News, March 2006

Bioppharma CMOs in China, Contract Pharma,
Eliza Yibing Zhou, June 2006

CMOs and the Outsourcing Dilemma,
World Pharmaceutical Frontiers, March 2006, p. 53

BioCapacity Q&A
Eric Langer, Contract Pharma, November 2005

ProcessStats Survey DataPoints, Genetic Engineering News,
March 15, 2006 Bi-weekly insert

The ROI Case: Economic Justification for Disposables in Biopharmaceutical Manufacturing,
Eric S. Langer, J. Ranck, BioProcess International, October 2005

Biopharmaceutical Products in the US and European Markets, 4th Edition,
Ronald A. Rader, BioPlan Associates, Inc. July 2005

3rd Annual Survey of Biopharmaceutical Manufacturers,
BioPlan Associates, Rockville, MD, June 2005

Advances in Large Scale Biopharmaceutical Manufacturing and Scale-up Production,
ASM Press, Washington, DC and ISTM Press, Rockville, MD, October 2004

Biopharmaceutical Manufacturing: No single approach will resolve cost issues. Genetic Engineering, November 15, 2004, News, New York, NY

Manufacturing Capacity put on Simmer,
BioProcess International, February 2004, p 22-28

Training Day for International Biopharma Manufacturers,
Contract Pharma, March 2004, www.contractpharma.com

Big Shifts in Outsourcing of Biopharmaceutical Manufacturing—Half of Manufacturers to Outsource production by 2008, Genetic Engineering News, January 15, 2004

2nd Annual Survey of Biopharmaceutical Manufacturers,
BioPlan Associates, Rockville, MD, November 2003

Manufacturers Must Cooperate to Compete—
Contract Pharma, October 2002, Rodman Publishing, Ramsey, NJ 07446

Opportunities in Stem Cell Technology,
Kalorama Information, February 2002

Market Profiles: Structural Tissue Engineering,
Kalorama Information, August, 2001

The Medical Marketplace: The Human Genome, Medical & Healthcare Marketplace Guide, 16th edition,
Dorland's Directories, Philadelphia, PA, 2001.

The Medical Marketplace: Laboratory Animals-Transgenic Animals, Medical & Healthcare Marketplace Guide, 16th edition,
Dorland's Directories, Philadelphia, PA, 2001.

The Medical Marketplace: Laboratory Animals, Medical & Healthcare Marketplace Guide, 16th edition,
Dorland's Directories, Philadelphia, PA, in publication 2001.

The Medical Marketplace: Tissue Engineering, Medical & Healthcare Marketplace Guide, 16th edition,
Dorland's Directories, Philadelphia, PA , 2001.

A Critical, Yet Simple Strategic Marketing Tool, Industrial Launderer, Vol.,
51, Arlington, VA, 2000

The Medical Marketplace: The Human Genome, Medical & Healthcare Marketplace Guide, 15th edition,
Dorland's Directories, Philadelphia, PA, 2000.

The Medical Marketplace: Laboratory Animals-Transgenic Animals, Medical & Healthcare Marketplace Guide, 15th edition,
Dorland's Directories, Philadelphia, PA, 2000.

The Medical Marketplace: Laboratory Animals, Medical & Healthcare Marketplace Guide, 15th edition,
Dorland's Directories, Philadelphia, PA, 2000.

The Medical Marketplace: Tissue Engineering, Medical & Healthcare Marketplace Guide, 15th edition,
Dorland's Directories, Philadelphia, PA, 2000.

Autologous Vaccines Genetic Engineering News,
volume 19, no. 21 (December 1999) pp. 1, 25, 30, 63.

The Medical Marketplace: The Human Genome, Medical & Healthcare Marketplace Guide, 14th edition,
Dorland's Directories, Philadelphia, PA, 1999.

The Medical Marketplace: Laboratory Animals-Transgenic Animals, Medical & Healthcare Marketplace Guide, 14th edition,
Dorland's Directories, Philadelphia, PA, 1999.

The Medical Marketplace: Laboratory Animals, Medical & Healthcare Marketplace Guide, 14th edition,
Dorland's Directories, Philadelphia, PA, 1999.

The Medical Marketplace: Tissue Engineering, Medical & Healthcare Marketplace Guide, 14th edition,
Dorland's Directories, Philadelphia, PA , 1999.

U.S. Biotech Symposium Focuses on Bioprocessing Genetic Engineering News,
volume 19, no. 1 (January 1, 1999) pp. 1,11, 14.

Industry Reviews Impact of FDA Modernization Genetic Engineering News,
volume 18, no. 20 (November 15, 1998) pp. 1,8, 47.

The Medical Marketplace: The Human Genome, Medical & Healthcare Marketplace Guide, 13th edition,
Dorland's Directories, Philadelphia, PA, 1998.

The Medical Marketplace: Laboratory Animals-Transgenic Animals, Medical & Healthcare Marketplace Guide, 13th edition,
Dorland's Directories, Philadelphia, PA, 1998.

The Medical Marketplace: Laboratory Animals, Medical & Healthcare Marketplace Guide, 13th edition,
Dorland's Directories, Philadelphia, PA, 1998.

The Medical Marketplace: Tissue Engineering,Medical & Healthcare Marketplace Guide, 13th edition,
Dorland's Directories, Philadelphia, PA, 1998.

Corporate Profile, MetaMorphix, Inc. Genetic Engineering News,
volume 18, no. 10 (May 15, 1998) pp. 28, 33.

The Medical Marketplace: The Human Genome, Medical & Healthcare Marketplace Guide, 13th edition,
Dorland's Directories, Philadelphia, PA, (1997), pp 40-42.

The Medical Marketplace: Laboratory Animals-Transgenic Animals, Medical & Healthcare Marketplace Guide, 13th edition,
Dorland's Dir, Philadelphia, PA, (1997), pp. 222-224.

The Medical Marketplace: Laboratory Animals, Medical & Healthcare Marketplace Guide, 13th edition,
Dorland's Directories, Philadelphia, PA, (1997), pp. 221-222.

The Medical Marketplace: Tissue Engineering, Medical & Healthcare Marketplace Guide, 13th edition,
(1997), pp 266-267.

Penetrating the Latin American Pharmaceutical Market Genetic Engineering News,
vol 17, no. 12 (August 1, 1997) pp. 1, 22, 36.

Validation Experts Call for Clear Standards Genetic Engineering News,
volume 17, no. 9, (June 1,1997) pp. 1, 14, 39.

Christine Kelly on the Establishment of the Women's Health Center at Syracuse VAMC, Veterans Health System Journal,
Baltimore, MD, (May/June, 1997), pp. 59.

VA at Cutting Edge of Substance Abuse Treatment, Veterans Health System Journal,
Baltimore, MD, (May/June, 1997) pp. 26.

Southern Research-Frederick Finds its Niche In Contract Research Services Genetic Engineering News,
volume 17, no. 7, (April 1,1997) pp. 26, 46.

Gene Therapy--Dreams of Vectors in a Bottle, Genetic Engineering News,
vol 17, no. 3, (February 1, 1997) pp. 8, 34.

The Medical Marketplace: Tissue Engineering, Medical & Healthcare Marketplace Guide, 12th edition,
IDD Enterprises, L.P., (1996) pp. 183-184.

The Medical Marketplace: Transgenic Animals, Medical & Healthcare Marketplace Guide, 12th edition,
IDD Enterprises, L.P., (1996) pp. 166-167.

The Medical Marketplace: Laboratory Animals, Medical & Healthcare Marketplace Guide, 12th edition,
IDD Enterprises, L.P., (1996) pp. 165-166.

Pivotal Trial of Artificial Skin Advances Tissue Engineering Industry, Genetic Engineering News,
volume 16, no. 2, (January 15, 1996) pp. 25.

Ernst & Young Reports that Biotech Industry Revenues Total $12.7 Billion, Genetic Engineering News,
volume 15, no. 18, (October 15, 1995) pp. 10, 36.

The Medical Marketplace: Tissue Engineering,” Medical & Healthcare Marketplace Guide, 11 edition
IDD Enterprises, L.P., (1995) pp. 141-142.

Public Opinion Remains Main Obstacle to Gene Altered Food Acceptance Genetic Engineering News,
volume 15, no. 13, (July, 1995) pp. 15, 44.

Bioprocess Companies Concentrate on Cutting Product Manufacturing Costs, Genetic Engineering News,
volume 15, no. 3, (February 1, 1995) pp. 10.

Conference Spotlights Tissue Engineering, Genetic Engineering News,
vol 15, no. 1, (January 1, 1995) pp. 1, 46, 47.

Companies Report Progress in Mucosal Vaccine Technology and Delivery Systems, Genetic Engineering News,
volume 14, no. 20, (November 15, 1994) pp. 1, 18, 32.

Maryland and Virginia Break Ground for New Biotechnology Facilities, Genetic Engineering News,
volume 14, no. 11, (June 1, 1994) pp. 32.

HGP Researchers Seek to Order Data Into Accessible Format, Genetic Engineering News,
volume 13, no. 20, (November 15, 1993) pp. 1, 3,25.

New Targets, Strategies and Delivery Modes Transform Field of Biotechnology Vaccines, Genetic Engineering News,
volume 13, no. 8, (April 15, 1993) pp. 1, 3, 12.

NIH Scientists Find New Ways to Conjugate Cytotoxic Agents to Antibodies, Genetic Engineering News,
volume 13, no. 20, (March 15, 1993) pp. 6, 20.

Validation Issues and the Development of New Product Assays Stressed at BioEast ‘93,
Genetic Engineering News, volume 13, no. 3, (February 15, 1993) pp. 1, 18, 32.

NIH Designs Tool to Improve Electrophoresis and Histology,
Genetic Engineering News, volume 13, no. 3, (February 1, 1993) pp. 1, 10.

ISO 9000 Standards Begin to Affect U.S. Biotech Companies
Genetic Engineering News, volume 13, no. 2, (January 15, 1993) pp. 1, 18.

Grants from NIGMS Help Train Scientists and Engineers for Biotechnology,
Genetic Engineering News, volume 12, no. 19, (December, 1992) pp. 30.

NIST and NIH Support Bioprocessing Research and Development Projects,
Genetic Engineering News, volume 12, no. 17, (November 1, 1992) pp. 18.

Diagnostic for Susceptibility to Rheumatoid Arthritis Developed at NIH,
Genetic Engineering News, volume 12, no. 10, (June 15, 1992) pp. 10, 19.

NIH Scientists Develop a Range of New Technologies for Tech Transfer
Genetic Engineering News, volume 14, no. 20, (May 15, 1992) pp. 7, 25.

NIH Researchers Develop Novel DYSTAL Neural Network System
Genetic Engineering News, volume 12, no. 18, (November 15, 1992) pp. 1, 10, 20.